Effect of switching from cigarette smoking to Platform 1 on exercise capacity

A randomized, controlled, open-label, 4-arm parallel group study to evaluate the effect of switching from cigarette smoking to the use of Platform 1 in healthy adult current smokers on exercise capacity and trainability


Authored by  PMI

This study is part of the global clinical assessment program of Platform 1. It is designed to provide scientific evidence to further substantiate the reduced risk potential of using a heated tobacco product (Platform 1) as compared to smoking cigarettes. The main goals of this exploratory study are to assess whether switching from cigarette smoking to using Platform 1 will influence: 1) maximum oxygen uptake during incremental exercise (VO2max) and exercise capacity, 2) ability to perform exercise training and thereby influence, 3) VO2max after 12 weeks of exercise training, 4) physiological parameters and biological health markers, and finally 5) physical activity levels in daily life.

Recruitment  Active, not recruiting
Study Results No Results Available
Enrollment  90
Study Type  Interventional
Other IDs P1-EXC-01-EU